Valuation: RushNet, Inc.

Market Cap 1.23Cr 1.05Cr 98.3L 89.98L 1.69Cr 117.35Cr 1.71Cr 12Cr 4.53Cr 59Cr 4.61Cr 4.51Cr 194.98Cr P/E 2020
13.3x
P/E 2021 55x
Enterprise Value 1.82Cr 1.56Cr 1.46Cr 1.33Cr 2.51Cr 174.07Cr 2.54Cr 17Cr 6.72Cr 87Cr 6.83Cr 6.68Cr 289.23Cr EV / Sales 2020
2.75x
EV / Sales 2021 1.77x
Free-Float
100%
Yield 2020 *
-
Yield 2021 -
1 week+9,900.00%
Current month+9,900.00%
1 month+9,900.00%
3 months+9,900.00%
6 months+9,900.00%
Current year+9,900.00%
1 week 0
Extreme 1.0E-6
0
1 month 0
Extreme 1.0E-6
0
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0
5 years 0
Extreme 1.0E-6
0.01
10 years 0
Extreme 1.0E-6
0.02
Manager TitleAgeSince
Chief Executive Officer - 04/03/2024
Chief Operating Officer 45 02/08/2021
Director TitleAgeSince
Chairman - 04/03/2024
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+9,900.00%+9,900.00%-80.00% 8.77T
-2.98%-2.63%-12.61%+61.45% 695.29Cr
+1.47%+2.56%-7.42%-14.93% 421.08Cr
+1.90%+0.97%+19.02% - 253.63Cr
+1.27%-0.54%+93.68%+2,191.41% 179.34Cr
-0.07%+0.70%-11.11%-28.89% 159.63Cr
-0.47%+0.39%-8.32%-9.24% 134.69Cr
+2.42%-4.37%+104.76% - 100Cr
-0.23%-0.30%-33.57%-33.06% 79Cr
-2.01%-6.87%-15.03%-9.27% 74Cr
Average +0.13%-1.24%+1,002.94%+259.68% 209.59Cr
Weighted average by Cap. -0.35%-0.75%+6.46%+241.22%

Financials

2020 2021
Net sales 43.88L 37.59L 35.17L 32.19L 60.42L 42Cr 61.22L 4.16Cr 1.62Cr 21Cr 1.65Cr 1.61Cr 70Cr 58.97L 50.51L 47.26L 43.26L 81.19L 56Cr 82.27L 5.58Cr 2.18Cr 28Cr 2.21Cr 2.17Cr 94Cr
Net income 10L 8L 8L 7L 13.64L 9.48Cr 13.82L 93.82L 36.59L 4.76Cr 37.2L 36.39L 16Cr 2L 1L 1L 1L 2L 1.56Cr 2L 15.49L 6L 78.61L 6L 6L 2.6Cr
Net Debt 58.7L 50.28L 47.05L 43.07L 80.82L 56Cr 81.89L 5.56Cr 2.17Cr 28Cr 2.2Cr 2.16Cr 93Cr 59.29L 50.79L 47.52L 43.5L 81.64L 57Cr 82.71L 5.61Cr 2.19Cr 28Cr 2.23Cr 2.18Cr 94Cr
Logo RushNet, Inc.
RushNet, Inc. provides management and insurance billing services to clinical laboratories and laboratory services. The Company’s subsidiaries include Chattahoochee Physicians Laboratory Services, LLC, doing business as HeliosDx, and Grandeza Healthcare Consultants, LLC (Grandeza). HeliosDx offers urine drug testing, allergy droplet cards, oral fluids, Polymerase Chain Reaction (PCR) for nails, wounds, respiratory pathogens, sexually transmitted infections, gastrointestinal issues, urinary tract infections, and pharmacogenomics testing through lab partners. Grandeza provides management and insurance billing services to clinical reference laboratories.
Employees
18
Date Price Change Volume
18/26/18 $0.000001 -.--% 1,40,000
  1. Stock Market
  2. Stocks
  3. RSHN Stock